News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
273,994 Results
Type
Article (14272)
Company Profile (105)
Press Release (259609)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88274)
Career Advice (465)
Deals (15393)
Drug Delivery (73)
Drug Development (36718)
Employer Resources (50)
FDA (6385)
Job Trends (6233)
News (150709)
Policy (14130)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (443)
Accelerated approval (13)
Adcomms (8)
Allergies (71)
Alliances (23317)
ALS (56)
Alzheimer's disease (479)
Antibody-drug conjugate (ADC) (101)
Approvals (6575)
Artificial intelligence (204)
Autoimmune disease (46)
Automation (13)
Bankruptcy (150)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (119)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (174)
Cancer (1330)
Cardiovascular disease (154)
Career advice (418)
Career pathing (13)
CAR-T (50)
CDC (6)
Cell therapy (157)
Cervical cancer (9)
Clinical research (32036)
Collaboration (742)
Compensation (329)
Complete response letters (34)
COVID-19 (779)
CRISPR (44)
C-suite (449)
Cystic fibrosis (58)
Data (1841)
Denatured (18)
Depression (45)
Diabetes (127)
Diagnostics (1385)
Digital health (10)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (120)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (82)
Earnings (33501)
Editorial (21)
Employer branding (4)
Employer resources (46)
Events (39004)
Executive appointments (537)
FDA (7489)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (438)
Gene editing (72)
Generative AI (18)
Gene therapy (168)
GLP-1 (443)
Government (1406)
Grass and pollen (4)
Guidances (164)
Healthcare (3578)
HIV (12)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (69)
Immuno-oncology (15)
Indications (55)
Infectious disease (846)
Inflammatory bowel disease (74)
Inflation Reduction Act (7)
Influenza (25)
Intellectual property (115)
Interviews (60)
IPO (5913)
IRA (33)
Job creations (2055)
Job search strategy (374)
JPM (29)
Kidney cancer (9)
Labor market (28)
Layoffs (205)
Leadership (8)
Legal (3449)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (420)
MASH (70)
Medical device (1303)
Medtech (1310)
Mergers & acquisitions (9904)
Metabolic disorders (442)
Multiple sclerosis (48)
NASH (14)
Neurodegenerative disease (83)
Neuropsychiatric disorders (38)
Neuroscience (893)
Neurotech (1)
NextGen: Class of 2026 (1588)
Non-profit (602)
Now hiring (18)
Obesity (231)
Opinion (141)
Ovarian cancer (39)
Pain (110)
Pancreatic cancer (52)
Parkinson's disease (80)
Partnered (11)
Patents (224)
Patient recruitment (121)
Peanut (12)
People (29772)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8311)
Phase 2 (13525)
Phase 3 (12213)
Pipeline (1968)
Policy (135)
Postmarket research (1401)
Preclinical (3342)
Press Release (25)
Prostate cancer (86)
Psychedelics (16)
Radiopharmaceuticals (136)
Rare diseases (354)
Real estate (2659)
Recruiting (19)
Regulatory (10971)
Reports (15)
Research institute (575)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (81)
Series B (53)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1646)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (238)
Venture capital (33)
Weight loss (142)
Women's health (28)
Worklife (4)
Date
Today (65)
Last 7 days (201)
Last 30 days (696)
Last 365 days (10469)
2026 (1143)
2025 (10712)
2024 (12499)
2023 (14246)
2022 (19557)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (78)
Arkansas (3)
Asia (20904)
Australia (2689)
California (3204)
Canada (1498)
China (559)
Colorado (146)
Connecticut (133)
Delaware (125)
Europe (40903)
Florida (609)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (352)
India (45)
Indiana (241)
Iowa (2)
Japan (250)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (425)
Massachusetts (2620)
Michigan (46)
Minnesota (168)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1411)
New Mexico (7)
New York (911)
North Carolina (628)
North Dakota (2)
Northern California (1459)
Ohio (81)
Oklahoma (5)
Oregon (18)
Pennsylvania (725)
Puerto Rico (13)
Rhode Island (17)
South America (508)
South Carolina (10)
Southern California (1403)
Tennessee (53)
Texas (456)
United States (12801)
Utah (60)
Virginia (161)
Washington D.C. (42)
Washington State (225)
West Virginia (1)
Wisconsin (38)
Wyoming (1)
273,994 Results for "adial pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
February 4, 2026
·
5 min read
Press Releases
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045
January 15, 2026
·
4 min read
Press Releases
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
November 27, 2025
·
5 min read
Press Releases
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
November 17, 2025
·
9 min read
Press Releases
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
October 10, 2025
·
9 min read
Press Releases
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting
August 7, 2025
·
5 min read
Press Releases
Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
August 15, 2025
·
9 min read
Press Releases
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
July 17, 2025
·
4 min read
Press Releases
Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule
September 4, 2025
·
4 min read
Press Releases
Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting
June 16, 2025
·
6 min read
1 of 27,400
Next
